PREMIER INTERNATIONAL CONFERENCE WILL HIGHLIGHT ADVANCEMENTS IN BIOLOGY AND POTENTIAL NEW THERAPIES.PHILADELPHIA — OCT. 27-30, 2010
FOLLOW US ON TWITTER: @AACR #AACR
Newswise — What:Colorectal cancer is the second leading cause of cancer deaths in the United States, with an estimated 51,370 deaths expected this year alone.
This October, the American Association for Cancer Research will host the special conference Colorectal Cancer: Biology to Therapy at the Loews Philadelphia Hotel. Hundreds of scientists, physicians and allied health professionals will gather and discuss new data on new screening methods and emerging therapies.
Findings presented at this year’s meeting will include:• validation studies of new genetics-based screening methods;• how scientists are targeting stem cells as a therapeutic option;• the role of inflammation in colorectal cancer;• new colon cancer inhibitors in development; and• earlier detection methods that will prevent mortality.
To help you plan your coverage of the conference, the program schedule is available online at www.aacr.org/colorectalprogram. An electronic press kit containing the press releases and selected highlighted abstracts will be available on Oct. 20 via EurekAlert, Newswise and to members of the media registered through the AACR Communications Department.
When:Oct. 27-30, 2010
Where:Loews Philadelphia HotelPhiladelphia, Pa.
Contact/Press Registration:Natalie Poole(267) 646-0619 / [email protected]Registration:
RSS